Engineering of erythropoietin receptor for use as an affinity ligand

Protein Expression and Purification
Kouta Hatayama, Teruhiko Ide

Abstract

Recombinant human erythropoietin receptor (rhEPOR) has applicability as an affinity ligand for purification of recombinant human erythropoietin (rHuEPO) because of its specific binding to rHuEPO. For application of rhEPOR as a ligand for purification of rHuEPO, soluble rhEPOR was expressed in the periplasm of Escherichia coli and engineered by directed evolution through random mutagenesis and integration of mutations. From the screening of random mutagenesis, we identified an amino acid mutation (H114Y) contributing to rHuEPO binding and four amino acid mutations (R76S, A132D, A162D, and C181Y) contributing to expression of soluble rhEPOR. However, the rHuEPO that binds to engineered rhEPOR having H114Y mutation is difficult to dissociate from the engineered rhEPOR. Therefore, H114Y mutation was not suitable for the construction of the rhEPOR ligand. As a rhEPOR ligand, engineered rhEPOR containing four amino acid mutations (EPORm4L) was constructed by integration of mutations except for H114Y. The expression of EPORm4L (127mgl(-1) of culture medium) was markedly increased in comparison with wild-type rhEPOR (2mgl(-1) of culture medium). Small-scale affinity chromatography demonstrated that EPORm4L worked as an affinity ligand ...Continue Reading

References

May 9, 1991·The New England Journal of Medicine·A J Erslev
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J MatthewsL B Giebel
Oct 12, 2010·Journal of Chromatography. a·Maria LönnbergJan Carlsson
Apr 19, 2011·ACS Combinatorial Science·María C Martínez-CeronSilvia A Camperi
Sep 13, 2012·Protein Engineering, Design & Selection : PEDS·Yoshiharu AsaokaTeruhiko Ide
Apr 25, 2013·Biotechnology and Bioengineering·Graziella El KhouryChristopher R Lowe
Nov 26, 2013·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Wolfgang Jelkmann

❮ Previous
Next ❯

Citations

Jan 16, 2016·Drug Testing and Analysis·Mario ThevisWilhelm Schänzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Progress in Clinical and Biological Research
J W Adamson, J W Eschbach
ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
A Besarab, J B McCrea
Le Journal CANNT = CANNT Journal : the Journal of the Canadian Association of Nephrology Nurses and Technicians
A Tan
Gastroenterología y hepatología
G Martín NúñezJ González Hurtado
© 2021 Meta ULC. All rights reserved